Bill · S. 735· Senate(119-S-735)
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
- Introduced
- 2/26/2025
- Last activity
- 2/26/2025 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Sponsored by
- Tim Scott
- Cosponsors
- - 0 - 3
- Introduced
- In Committee
What this bill would do
This bill, titled the "Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025," seeks to amend the Public Health Service Act. It focuses on reauthorizing a demonstration program regarding sickle cell disease. The legislation expands the scope of the program to include the prevention and treatment of complications associated with the disease. Additionally, it modifies how entities can receive support through grants, contracts, or cooperative agreements. Finally, it increases the funding allocated for the program for specific fiscal years.
Yes· 3 of 6
Would Black Americans be better off under this?+5
The bill increases funding and expands the scope of care for sickle cell disease, which disproportionately affects the Black community.
Does this make health care easier to get in general?+5
The bill expands the scope of the demonstration program to include the prevention and treatment of complications of sickle cell disease.
Does this put more money into medical research?+5
The bill increases the annual allocation for the sickle cell demonstration program to $8,205,000 for fiscal years 2025 through 2029.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Expanded Medical Scope: The bill changes the focus from just the "prevention and treatment of sickle cell disease" to include the "treatment of sickle cell disease and the prevention and treatment of complications of sickle cell disease" (Section 2(a)(1), Section 2(a)(2), and Section 2(a)(3)(B)). This could help patients manage the various health issues that arise from the disease rather than just the disease itself.
-
Increased Funding: The bill increases the allocated amount to "$8,205,000 for each of fiscal years 2025 through 2029" (Section 2(a)(4)). This provides more financial resources to support the program compared to the previous funding levels.
-
Flexible Support Methods: The bill allows for making a grant to, or entering into a contract or cooperative agreement with, entities (Section 2(a)(3)(A)). This provides more ways for the program to distribute resources to those doing the work.
Potential Negative Impacts for People
- No negative impacts or burdens are explicitly stated in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For African Americans+5Good For Low Income Households+3Good For People With Disabilities+3
- Healthcare
- Improves Healthcare Access+5Increases Research Funding+5
- Social Issues And Justice
- Improves Racial Equity+3
- 12/18/2025
- 1 Cosponsor added.
- 12/8/2025
- 1 Cosponsor added.
- 2/26/2025
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 1 Cosponsor added.
- Introduced in Senate
4 bills Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Cory BookerDemocrat · New Jersey
Jon OssoffDemocrat · Georgia
Raphael WarnockDemocrat · Georgia